Peptide-mediated cell transport of water soluble porphyrin conjugates

Journal of Medicinal Chemistry

Volumn 49, Issue 4, 2006, Pages 1364-1372

  Sibrian Vazquez, Martha ^a   Jensen, Timothy J ^a   Hammer, Robert P ^a   Vicente, M Graça H ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARBOXYLIC ACID DERIVATIVE; MACROCYCLIC COMPOUND; MACROGOL; PEPTIDE DERIVATIVE; PORPHYRIN DERIVATIVE; TRANSACTIVATOR PROTEIN; WATER;

AMINO ACID SEQUENCE; ARTICLE; CELL TRANSPORT; CONJUGATE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TRANSPORT; ENDOPLASMIC RETICULUM; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; IC 50; IN VITRO STUDY; LYSOSOME; MOLECULAR WEIGHT; NUCLEAR LOCALIZATION SIGNAL; PHOTOTOXICITY; SOLUBILITY;

ARGININE; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; DARKNESS; DRUG CARRIERS; ENDOPLASMIC RETICULUM; GENE PRODUCTS, TAT; HUMANS; LIGHT; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHOTOSENSITIZING AGENTS; PORPHYRINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33144484648     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050893b     Document Type: Article

References (77)

1. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90, 889-905.
2. Pandey, R. K.; Zheng, G. Porphyrins as photosensitizers in photodynamic therapy. In The Porphyrin Handbook; Kadish, K. M., Smith, K. M., Guilard, R., Eds.; Academic Press: Boston, MA, 2000; Vol. 6, pp 157-230.
3. Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F. G.; Barth, R. F.; Codogni, I. M.; Wilson, J. G. The chemistry of neutron capture therapy. Chem. Rev. 1998, 98, 1515-1562.
4. Barth, R. F.; Coderre, J. A.; Vicente, M. G. H.; Blue, T. E. Boron neutron capture therapy of cancer: Current status and future prospects. Clin. Cancer Res. 2005, 11, 3987-4002.
5. 10B neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. Int. J. Radiat. Oncol., Biol., Phys. 1985, 11, 831-840.
6. 7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiat. Res. 1987, 111, 14-25.
7. (a) Hartman, T.; Carlsson, J. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy. Radiother. Oncol. 1994, 31, 61-75.
8. (b) Hartman, T.; Lundqvist, H.; Westlin, J.-E.; Carlsson, J. Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with I-131 labeled ligands or antibodies. Int. J. Radiat. Oncol. Biol., Phys. 2000, 46, 1025-1036.
9. (a) Hamblin, M. R.; Newman, E. L. Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin. J. Photochem. Photobiol. B: Biol. 1994, 26, 45-56.
10. (b) Hamblin, M. R.; Newman, E. L. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J. Photochem. Photobiol. B: Biol. 1994, 26, 147-157.
11. Soini, A. E.; Yashunsky, D. V.; Meltola, N. J.; Ponomarev, G. V. Influence of linker unit on performance of palladium(11) coproporphyrin labelling reagent and its bioconjugates. Luminescence 2003, 18, 182-92.
12. Chudinov, A. V.; Rumiantseva, V. D.; Lobanov, A. V.; Chudinova, G. K.; Stomakhin, A. A.; Mironov, A. F. Synthesis of conjugates of bovine serum albumin with water-soluble ytterbium porphyrins. Bioorg. Khim. 2004, 30, 99-104.
13. Li, H.; Fedorova, O. S.; Trumble, W. R.; Fletcher, T. R.; Czuchajowski, L. Site-specific photomodification of DNA by porphyrin-oligonucleotide conjugates synthesized via a solid-phase H-phosphonate approach. Bioconj. Chem. 1997, 8, 49-56.
14. (a) Mestre, B.; Jakobs, A.; Pratviel, G.; Meunier, B. Structure/nuclease activity relationships of DNA cleavers based on cationic metalloporphyrin- oligonucleotide conjugates. Biochemistry 1996, 35, 9140-9149.
15. (b) Mestre, B.; Pitie, M.; Loup, C.; Claparols, C.; Pratviel, G.; Meunier, B. Influence of the nature of the porphyrin ligand on the nuclease activity of metalloporphyrin-oligonucleotide conjugates designed with cationic, hydrophobic or anionic metalloporphyrins. Nucleic Acids Res. 1997, 25, 1022-1027.
16. Bedel-Cloutour, C. H.; Mauclaire, L.; Saux, A.; Pereyre, M. Syntheses of functionalized indium porphyrins for monoclonal antibody labeling. Bioconj. Chem. 1996, 7, 617-627.
17. 6 immunoconjugates. Br. J. Cancer 2000, 82, 56-64.
18. (b) Hamblin, M. R.; Del Governatore, M.; Rizvi, I.; Hasan, T. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br. J. Cancer 2000, 83, 1544-1551.
19. Hudson, R.; Carcenac, M.; Smith, K.; Madden, L.; Clarke, O. J.; Pelegrin, A.; Greenman, J.; Boyle, R. W. The development and characterization of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br. J. Cancer 2005, 92, 1442-1449.
20. Savitsky, A. A.; Gukasova, N. V.; Gumanov, S. G.; Feldman, N. B.; Luk'yanets, E. A.; Mironov, A. F.; Yakubovskaya, R. I.; Lutsenko, S. V.; Severin, S. E. Cytotoxic action of conjugates of alpha-fetoprotein and epidermal growth factor with photoheme, chlorines, and phthalocyanines. Biochemistry (Moscow) 2000, 65, 732-736.
21. 6 internalizable conjugates on A431 cells. Int. J. Oncol. 1998, 13, 1171-1177.
22. 6 selectively potentiates its photodynamic activity. Cancer Res. 2000, 60, 2197-2202.
23. Chen, X.; Hui, L.; Foster, D. A.; Drain, C. M. Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells. Biochemistry 2004, 43, 10918-10929.
24. Li, G.; Pandey, S. K.; Graham, A.; Dobhal, M. P.; Mehta, R.; Chen, Y.; Gryshuk, A.; Rittenhouse-Olson, K.; Oseroff, A.; Pandey, R. K. Functionalization of OEP-based benzochlorins to develop carbohydrate-conjugated photosensitizers. Attempt to target beta-galactoside-recognized proteins. J. Org. Chem. 2004, 69, 158-172.
25. 6) conjugates. Photochem. Photobiol. 1997, 65, 723-729.
26. (b) Hamblin, M. R.; O'Donnell, D. A.; Murthy, N.; Rajagopalan, K.; Michaud, N.; Sherwood, M. E.; Hasan, T. Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J. Antimicrob. Chemother. 2002, 49, 941-951.
27. (a) Omelyanenko, V.; Gentry, C.; Kopeckova, P.; Kopecek, J. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Int. J. Cancer 1998, 75, 600-608.
28. 6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. Int. J. Oncol. 1999, 15, 5-16.
29. (c) Tijerina, M.; Kopeckova, P.; Kopecek, J. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates. Photochem. Photobiol. 2003, 77, 645-652.
30. (d) Tijerina, M.; Kopeckova, P.; Kopecek, J., Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells. Pharm. Res. 2003, 20, 728-737.
31. Rosenkranz, A. A.; Jans, D. A.; Sobolev, A. S. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol. Cell Biol. 2002, 78, 452-464.
32. Hudson, R.; Boyle, R. W. Strategies for selective delivery of photodynamic sensitizers to biological targets. J. Porphyrins Phthalocyanines 2004, 8, 954-975.
33. Osterloh, J.; Vicente, M. G. H. Mechanisms of porphyrinoid localization in tumors. J. Porphyrins Phthalocyanines 2002, 6, 305-324.
34. Kessel, D. Correlation between subcellular localization and photodynamic efficacy. J. Porphyrins Phthalocyanines 2004, 8, 1009-1014.
35. Kalderon, D.; Roberts, B. L.; Richardson, W. D.; Smith, A. E. A short amino acid sequence able to specify nuclear location. Cell 1984, 39, 499-509.
36. Boulikas, T. Nuclear localization signals. Crit. Rev. Eukariotic Gene Expression 1993, 3, 193-227.
37. Lombardo, E.; Ramirez, J. C.; Garcia, J.; Almendral, J. M. Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset of the infection. J. Virol. 2002, 76, 7049-7059.
38. (a) Lanford, R. E.; Butel, J. S. Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 1984, 37, 801-813.
39. (b) Lanford, R. E.; Kanda, P.; Kennedy, R. C. Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell 1986, 46, 575-582.
40. (c) Feldherr, C. M.; Lanford, R. E.; Akin, D. Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11002-11005.
41. 6 alone. Biochem. Int. 1992, 26, 445-450.
42. 6 for increasing its photosensitizing activity. Photochem. Photobiol. 1993, 58, 45-48.
43. 6 enhances its photosensitizing activity. J. Biol. Chem. 1997, 272, 20328-20331.
44. 6. Int. J. Cancer 1999, 81, 734-740.
45. Chaloin, L.; Bigey, P.; Loup, C.; Marin, M.; Galeotti, N.; Piechaczyk, M.; Heitz, F.; Meunier, B. Improvement of porphyrin cellular delivery and activity by conjugation to a carrier peptide. Bioconj. Chem. 2001, 12, 691-700.
46. 6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconj. Chem. 1999, 10, 982-992.
47. Sibrian-Vazquez, M.; Jensen, T. J.; Fronczek, F. R.; Hammer, R. P.; Vicente, M. G. H. Synthesis and characterization of positively charged porphyrin-peptide conjugates. Bioconj. Chem. 2005, 16, 852-863.
48. (a) Schwartz, J. J.; Zhang, S. Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther. 2000, 2, 162-167.
49. (b) Lundberg, P.; Langel, U. A brief introduction to cell-penetrating peptides. J. Mol. Recognit. 2003, 16, 227-233.
50. (c) Richard, J. P.; Melikov, K.; Vives; E.; Ramos, C.; Verbeure, B.; Gait, M. J.; Chernomordik, L. V.; Lebleu, B. Cell-penetrating peptides: a reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 2003, 278, 585-590.
51. (d) Futaki, S.; Goto, S.; Suzuki, T.; Nakase, I.; Sugiura, Y. Structural variety of membrane permeable peptides. Curr. Protein Pept. Sci. 2003, 4, 87-96.
52. Derossi, D.; Joliot, A.; Chassaing, G.; Prochiantz, A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269, 10444-10450.
53. Vives, E. Cellular uptake of the Tat peptide: an endocytosis mechanism following ionic interactions. J. Mol. Recognit. 2003, 16, 265-271.
54. (a) Normand, N.; van Leeuwen, H.; O'Hare, P. Particle formation by the HSV protein VP22 enabling protein and nucleic acid delivery. J. Biol. Chem. 2001, 276, 15042-15050.
55. (b) Brewis, N. D.; Phelan, A.; Normand, N.; Choolun, E.; O'Hare, P. Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis 1. Mol. Ther. 2003, 7, 262-270.
56. (a) Mitchell, D. J.; Kim, D. T.; Steinman, L.; Fathman, C. G.; Rothbard, J. B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 2000, 56, 318-325.
57. (b) Rothbard, J. B.; Jessop, T. C.; Lewis, R. S.; Murray, B. A.; Wender, P. A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 2004, 126, 9506-9507.
58. (a) Rothbard, J. B.; Garlington, S.; Lin, Q.; Kirschberg, T.; Kreider, E.; McGrane, P. L.; Wender, P. A.; Khavari, P. A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 2000, 6, 1253-1257.
59. (b) Futaki, S.; Ohashi, W.; Suzuki, T.; Niwa, M.; Tanaka, S.; Ueda, K.; Harashima, H.; Sugiura, Y. Stearylated arginine-rich peptides: A new class of transfection systems. Bioconj. Chem. 2001, 12, 1005-1011.
60. (c) Kirschberg, T. A.; VanDeusen, C. L.; Rothbard, J. B.; Yang, M.; Wender, P. A. Arginine-based molecular transporters: The synthesis and chemical evaluation of releasable taxol-transporter conjugates. Org. Lett. 2003, 5, 3459-3462.
61. (a) Greenwald, R. B. PEG drugs: an overview. J. Controlled Release 2001, 74, 159-171.
62. (b) Greenwald, R. B.; Choe, Y. H.; McGuire, J.; Conover, C. D. Effective drug delivery by PEGylated drug conjugates. Adv. Drug Delivery Rev. 2003, 55, 217-250.
63. 6 polymer conjugate increases tumor targeting of photosensitizer. Cancer Res. 2001, 61, 7155-7162.
64. (b) Kim, Y. S.; Song, R.; Hyun Kim, D.; Jun, M. J.; Sohn, Y. S. Synthesis, biodistribution and antitumor activity of hematoporphyrin- platinum(II) conjugates. Bioorg. Med. Chem. 2003, 111, 1753-1760.
65. (a) Lottner, C.; Bart, K. C.; Bernhardt, G.; Brunner, H. Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents. J. Med. Chem. 2002, 45, 2079-2089.
66. (b) Lottner, C.; Bart, K. C.; Bernhardt, G.; Brunner, H. Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity. J. Med. Chem. 2002, 45, 2064-2078.
67. (c) Lottner, C.; Knuechel, R.; Bernhardt, G.; Brunner, H. Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates. Cancer Lett. 2004, 203, 171-180.
68. Nori, A.; Kopecek, J. Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Adv. Drug Delivery Rev. 2005, 57, 609-636.
69. (a) Suedhem, S.; Hollander, S.; Shi, J.; Konradsson, P.; Liedberg, B.; Svensson, S. C. T. Synthesis of a series of oligo(ethyleneglycol)-terminated alkanethiol amides designed to address structural and stability of biosensing interfaces. J. Org. Chem. 2001, 66, 4494-4503.
70. (b) Wosnick, J. H.; Charlene M.; Mello, C. M.; Swager, T. M. Synthesis and application of poly(phenylene ethynylene)s for bioconjugation: A conjugated polymer-based fluorogenic probe for proteases. J. Am. Chem. Soc. 2005, 127, 3400-3405.
71. Luguya, R.; Jaquinod, L.; Fronczek, F. R.; Vicente, M. G. H.; Smith, K. M. Synthesis and reactions of meso-(p-nitrophenyl)porphyrins. Tetrahedron 2004, 60, 2757-2763.
72. Greenfield, N.; Fasman, G. D. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 1969, 8, 4108-4116.
73. Conti, E.; Uy, M.; Leighton, L.; Blobel, G.; Kuriyan, J. Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import facto kariopherin α. Cell 1988, 94, 193-204.
74. Loret, E. P.; Vives, E.; Pui Shing Ho, P. S.; Rochat, H.; Van Rietschoten, J.; Johnson, W. C., Jr. Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization. Biochemistry 1991, 30, 6013-6023.
75. Dozzo, P.; Koo, M.-S.; Berger, S.; Forte, T. M.; Kahl, S. B. Synthesis, characterization, and plasma lipoprotein association of a nucleus-targeted boronated porphyrin. J. Med. Chem. 2005, 48, 357-359.
76. Groenendyk, J.; Michalak, M. Endoplasmic reticulum quality control and apotosis. Acta Biochim. Pol. 2005, 52, 381-395.
77. Rao, R. V.; Hermel, E.; Castro-Obregon, S.; del Rio, G.; Ellerby, L. M.; Ellerby, H. M.; Bredesen, D. E. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 2001, 276, 33869-33874.